2024年美国临床肿瘤学会胃肠肿瘤研讨会(ASCO-GI)食管癌治疗进展解读  

Interpretation of the progress in esophageal cancer treatment in the 2024 American Society of Clinical Oncology Gastrointestinal Cancer Symposium

作　　者：张旭旭 李俊海 徐欣瑶 李家贺 张继朋 李玮 王磊 卢强 ZHANG Xuxu;LI Junhai;XU Xinyao;LI Jiahe;ZHANG Jipeng;LI Wei;WANG Lei;LU Qiang(Shaanxi University of Chinese Medicine,Xianyang,712046,Shaanxi,P.R.China;Department of Thoracic Surgery,The Second Affiliated Hospital,Air Force Medical University,Xi’an,710038,P.R.China;Department of Thoracic Surgery,Xincai People's Hospital of Henan Province,Xincai,463500,Henan,P.R.China)

机构地区：[1]陕西中医药大学,陕西咸阳712046 [2]空军军医大学第二附属医院胸腔外科,西安710038 [3]河南省新蔡县人民医院胸腔外科,河南新蔡463500

出　　处：《中国胸心血管外科临床杂志》2024年第6期807-813,共7页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

基　　金：空军军医大学第二附属医院临床研究(2021LCYJ008);空军军医大学第二附属医院“精英人才培育资助计划-尖子人才”;空军军医大学第二附属医院新技术新业务(XJSXYW-2023011,XJSXYW-2021001)。

摘　　要：2024年美国临床肿瘤学会胃肠肿瘤研讨会(American Society of Clinical Oncology Gastrointestinal Cancers Symposium,ASCO-GI)于当地时间1月18—20日在美国旧金山举行。本次大会报道的多个研究将对食管癌的临床实践产生重要影响。本文将从食管癌的手术方式、围手术期免疫治疗、晚期食管癌药物治疗和免疫治疗耐药后解救治疗等角度出发,整理及解读此次大会中食管癌领域的重要进展。The 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium(ASCO-GI)was held in San Francisco,the USA from January 18th to 20th,2024(local time).The multiple studies presented in this symposium will have a significant impact on the clinical practice of esophageal cancer.This article will focus on the surgical methods of esophageal cancer,perioperative immunotherapy,drug therapy for advanced esophageal cancer,rescue treatment after immunotherapy resistance,and other relevant aspects.It aims to summarize and interpret the significant advancements in the field of esophageal cancer presented in this symposium.

关 键 词：食管癌 美国临床肿瘤学会胃肠肿瘤研讨会 临床治疗 解读 

分 类 号：R73[医药卫生—肿瘤]